Open Access
Issue
Cah. Myol.
Number 25, juillet 2022
Page(s) 6 - 9
Section Mise au point / Focus
DOI https://doi.org/10.1051/myolog/202225003
Published online 11 août 2022
  1. Layzer RB, Shearn MA, Satya-Murti S. Eosinophilic polymyositis. Ann Neurol 1977 ; 1 : 65–71. [CrossRef] [PubMed] [Google Scholar]
  2. Kumamoto T, Ueyama H, Fujimoto S, et al. Clinicopathologic characteristics of polymyositis patients with numerous tissue eosinophils. Acta Neurol Scand 1996 ; 94 : 110–4. [CrossRef] [PubMed] [Google Scholar]
  3. Selva-O’Callaghan A, Trallero-Araguás E, Grau JM. Eosinophilic myositis: an updated review. Autoimmun Rev 2014 ; 13 : 375–8. [CrossRef] [PubMed] [Google Scholar]
  4. Hall FC, Krausz T, Walport MJ. Idiopathic eosinophilic myositis. QJM Mon J Assoc Physicians 1995 ; 88 (8) : 581–6. [Google Scholar]
  5. Gallay L, Hot A, Petiot P, et al. Focal myositis: New insights on diagnosis and pathology. Neurology 2018 ; 90 : e1013–20. [CrossRef] [PubMed] [Google Scholar]
  6. Muqit MMK, Taylor RH. Cyclical orbital eosinophilic myositis. Br J Ophthalmol 2007 ; 91 : 1569–70. [CrossRef] [PubMed] [Google Scholar]
  7. Galindo-Ferreiro A, Torres Nieto MA, Barbado Ajo J, et al. Focal eosinophilic myositis affecting the orbicularis muscle: Clinical and image aspects. Ophthal Plast Reconstr Surg 2020 ; 36 : e51–3. [CrossRef] [PubMed] [Google Scholar]
  8. Roh YH, Koh YD, Noh JH, et al. Focal Eosinophilic myositis of the hand presenting as a refractory pyogenic infection. J Hand Surg 2017 ; 42 (842) : e1–842.e3. [CrossRef] [Google Scholar]
  9. Sharma P, Sharma MC. Resolving Eosinophilic Myositis: MR Features. J Comput Assist Tomogr 2001 ; 25 : 151–3. [CrossRef] [PubMed] [Google Scholar]
  10. Hamada S, Ueki S, Miyabe Y, et al. Focal eosinophilic myositis with Charcot-Leyden crystal formation. Allergol Int Off J Jpn Soc Allergol 2020 ; 69 : 633–5. [CrossRef] [Google Scholar]
  11. Yamashita S, Kawasumi H, Kimura M, et al. Spontaneous resolution of focal eosinophilic myositis of the adductor pollicis complicated by lung lesions. Mod Rheumatol Case Rep 2020 : 106–9. [CrossRef] [PubMed] [Google Scholar]
  12. Nakashima M, Kawabe Y, Aoyagi T, et al. A case of eosinophilic myositis associated with orbital myositis. Mod Rheumatol 2002 ; 12 : 80–3. [CrossRef] [PubMed] [Google Scholar]
  13. Kaufman LD, Kephart GM, Seidman RJ, et al. The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum 1993 ; 36 : 1014–24. [CrossRef] [PubMed] [Google Scholar]
  14. Serratrice G, Pellissier JF, Roux H, et al. Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia. Muscle Nerve 1990 ; 13 : 385–95. [CrossRef] [PubMed] [Google Scholar]
  15. Kita H, Eosinophils : multifaceted biological properties and roles in health and disease. Immunol Rev 2011 ; 242 : 161–77. [CrossRef] [PubMed] [Google Scholar]
  16. Cantarini L, Volpi N, Carbotti P, et al. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms. J Clin Pathol 2009 ; 62 : 442–7. [CrossRef] [PubMed] [Google Scholar]
  17. Sugihara R, Kumamoto T, Ito T, et al. Human muscle protein degradation in vitro by eosinophil cationic protein (ECP). Muscle Nerve 2001 ; 24 : 1627–34. [CrossRef] [PubMed] [Google Scholar]
  18. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975 ; 88 : 70–86. [PubMed] [Google Scholar]
  19. Lebeaux D, Sène D. Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 2012 ; 26 : 449–58. [CrossRef] [PubMed] [Google Scholar]
  20. Toquet C, Hamidou MA, Renaudin K, et al. In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol 2003 ; 30 : 1811–5. [PubMed] [Google Scholar]
  21. El-Beshbishi SN, Ahmed NN, Mostafa SH, et al. Parasitic infections and myositis. Parasitol Res 2012 ; 110 : 1–18. [CrossRef] [PubMed] [Google Scholar]
  22. Krahn M, Goicoechea M, Hanisch F, et al. Eosinophilic infiltration related to CAPN3 mutations: a pathophysiological component of primary calpainopathy? Clin Genet 2011 ; 80 : 398–402. [CrossRef] [PubMed] [Google Scholar]
  23. Krahn M, Hanisch F, Goicoechea M, et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis: A predystrophic stage of LGMD2A? Neuromuscul Disord 2007 ; 17 : 791–2. [CrossRef] [Google Scholar]
  24. Baumeister SK, Todorovic S, Milić-Rasić V, et al. Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy. Neuromuscul Disord 2009 ; 19 : 167–71. [CrossRef] [PubMed] [Google Scholar]
  25. Brown RH, Amato A. Calpainopathy and eosinophilic myositis. Ann Neurol 2006 ; 59 : 875–7. [CrossRef] [PubMed] [Google Scholar]
  26. Schröder T, Fuchss J, Schneider I, et al. Eosinophils in hereditary and inflammatory myopathies. Acta Myol 2013 ; 32 : 148–53. [PubMed] [Google Scholar]
  27. Parent ME, Larue S, Ellezam B. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis. BMC Musculoskelet Disord 2014 ; 15 : 388. [CrossRef] [PubMed] [Google Scholar]
  28. Uehara M, Hashimoto T, Sasahara E, et al. Churg-Strauss syndrome presenting as myositis following unaccustomed exercise. J Clin Neurosci 2009 ; 16 : 1232–3. [CrossRef] [PubMed] [Google Scholar]
  29. Tamaki H, Chatterjee S, Langford CA. Eosinophilia in Rheumatologic/Vascular Disorders. Immunol Allergy Clin North Am 2015 ; 3 : 453–76. [CrossRef] [PubMed] [Google Scholar]
  30. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009 ; 124 : 1319–25. [CrossRef] [PubMed] [Google Scholar]
  31. Waheed S, Zubair H, Waheed F. Treatment of eosinophilic myositis with mepolizumab. Indian J Rheumatol 2018 ; 13 : 289. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.